Based on this YouTube video's total view count of 58.1K views and industry-standard rates, the estimated total earning is $41 - $116 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

Explore Ozempic Is Worse And Better Than You Think with 58,198 views, 1,828 likes, and 292 comments. Experience the impact of this video content that has captured audience attention.

Our Discord Community (FREE): https://discord.com/invite/Efbjh7Qj4V 📚 Review our sources ►https://pastebin.com/iGUHi2eR 💻 Check out our other socials ► linktr.ee/2and20 ✋ Get in touch ► [email protected] GLP-1 drugs like Ozempic are the fastest-growing drug class in history, with 50 million people expected to be on them by 2030. They don't just kill appetite. Studies show they reduce cravings for alcohol, nicotine, and even gambling. Jefferies estimates US airlines alone would save $580 million a year just from lighter passengers. But an annual course costs $15,000, Medicare won't cover it for weight loss, and the WHO says these drugs will reach less than 10% of the people who need them. In this video, we break down what the post-Ozempic economy actually looks like, who wins, who loses, and why the people who need it most are the last ones to get it. 00:00 - Intro 01:50 - Moderation Molecules 04:13 - The Skinny Economy 07:48 - The Price of Progress 12:13 - Ozempic for the Rich, Body Positivity for Everyone Else Includes music by Tom Fox – tomfox.site

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.